| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.26 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |